Conference Announcement

The speakers and dates for the 5th Ottawa International Conference on Neuromuscular Disease & Biology have been announced.

The Conference will feature top international basic and clinical NMD researchers highlighting advances in NMD research and clinical care, including novel diagnostic techniques, disease pathogenesis, basic muscle and stem cell biology, and promising therapies to treat these devastating disorders. Sessions are organized to include basic, translational and clinical presentations to engage all attendees regardless of background or training.

The Conference will be held at ‘The Westin Ottawa,’ a premier hotel and world-class conference facility from the 17th -19th of October 2019. Ottawa, as the capital of Canada, is a vibrant city offering award-winning museums, a dynamic and culturally diverse downtown and excellent cuisine.

Registration will open April 2019. 

For more information visit the Ottawa NMD 2019 website.

D1EBvRhU4AA0_O1

Read next...

researcher of the year 2025

Dr. Hanns Lochmüller Awarded “Clinical Researcher of the Year” by University of Ottawa Faculty of Medicine

We are thrilled to announce that Dr. Hanns Lochmüller has been awarded the Clinical Researcher of the Year Award by the University of Ottawa Faculty...
Holland study

New Publication: Galactose treatment rescues neuromuscular junction transmission in glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) deficient mice

Congenital Myasthenic Syndromes (CMS) are a group of rare inherited neuromuscular disorders caused by genetic defects at the neuromuscular junction (NMJ). Patients with CMS experience...
award winners

Celebrating Lab Members’ Recent Research Awards

We are thrilled to celebrate Kelly Ho for receiving first place for her poster presentation at this year’s American Society for Pharmacology and Experimental Therapeutics...
New publication - RTD (2)

Meet The Lochmüller Lab’s Newest Members!

Our research team is growing! We are excited to introduce three new members who have recently joined the Lochmüller lab and several students who will...
McMillan smart study (1)

New Clinical Study Examines Safety and Efficacy of IV Onasemnogene Abeparvovec in Broad SMA Cohort

Pediatric neurologist Dr Hugh McMillan publishes clinical study examining the safety and efficacy of IV onasemnogene abeparvovec in the broadest cohort of SMA patients to...
Text reading: Solve-RD publication: Solve-RD flagship publication: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Photos of Dr Kiran Polavarapu, Dr Rachel Thompson, Dr Hanns Lochmüller.

Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...